Sleep Fit Medical - Sleep & Weight Management Center (Dr. Rafael Sepulveda & Damaris Huang PA-C)
Sleep Fit Medical - Sleep & Weight Management Center (Dr. Rafael Sepulveda & Damaris Huang PA-C) · 369 Perkins Street · Sonoma, CA 95476
4.7· 15 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Medically supervised weight loss
About this practice
Sleep Fit Medical is a sleep medicine and medical weight-management practice in Sonoma, California, under the care of Dr. Rafael Sepulveda. Its website says the practice integrates evidence-based treatment for weight management and sleep disorders with patient-centered care in a relaxed, inclusive setting, and that a sleep evaluation may include a home sleep test or an attended sleep study. The site lists a physician with ABOM certification. Google shows a 4.7-star rating across 15 reviews dating back to 2022, with one in the past year; reviewers most often mention the staff, and a few mention results and the team's knowledge.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2026-06-02. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★4.7 across 15 Google reviews. Of the 12 reviews we analyzed, 11 (92%) are positive (4–5★) and 1 (8%) are negative (1–2★).
What patients like
- Friendly, helpful staff6 reviews
- Knowledgeable, professional providers3 reviews
- Weight-loss results2 reviews
- Feeling listened to2 reviews
Common complaints
Very few complaints — only 1 negative review, with no recurring theme.
Most recent Google reviews
Susan G.★★★★★2026-06-02I would give 0 stars if possible. Had a sleep study 5 weeks ago neither my PCP nor I have been contacted or given any results.
Julianna B.★★★★★2024-08-02Amazing!! Everyone was so nice and helpful!
Heidi L.★★★★★2024-05-21Great staff! Attentive doctor. The office is inviting and friendly
Kar (.★★★★★2024-01-21Great staff and great approach. Lost 70 pounds over the course of 11 months, went from a BMI of 34.5 to 23.3. Looking and feeling great for the first time in over a decade!
Devon F.★★★★★2024-01-20Dr Rafa is the best. I feel so much better every day, and it's nice to find a kind and supportive sleep doctor in the area! Plus, his staff and offices are organized and well-run. Highly recommend.
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Clinicians
- Sleep Fit Medical - Sleep & Weight Management Center (Dr. Rafael Sepulveda & Damaris Huang PA-C)
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs